KR101204145B1 - 비시클로〔３．１．０〕헥산 유도체의 제조 방법, 및 이에 대한 중간체 - Google Patents

비시클로〔３．１．０〕헥산 유도체의 제조 방법, 및 이에 대한 중간체 Download PDF

Info

Publication number
KR101204145B1
KR101204145B1 KR1020067011065A KR20067011065A KR101204145B1 KR 101204145 B1 KR101204145 B1 KR 101204145B1 KR 1020067011065 A KR1020067011065 A KR 1020067011065A KR 20067011065 A KR20067011065 A KR 20067011065A KR 101204145 B1 KR101204145 B1 KR 101204145B1
Authority
KR
South Korea
Prior art keywords
alkyl
substituted
halogen
alkoxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067011065A
Other languages
English (en)
Korean (ko)
Other versions
KR20060131771A (ko
Inventor
프레데릭 더블유. 하트너
루시 탄
노부요시 야스다
나오끼 요시까와
Original Assignee
다이쇼 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이쇼 세이야꾸 가부시끼가이샤 filed Critical 다이쇼 세이야꾸 가부시끼가이샤
Publication of KR20060131771A publication Critical patent/KR20060131771A/ko
Application granted granted Critical
Publication of KR101204145B1 publication Critical patent/KR101204145B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08—Saturated compounds having a carboxyl group bound to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020067011065A 2003-11-07 2004-11-03 비시클로〔３．１．０〕헥산 유도체의 제조 방법, 및 이에 대한 중간체 Expired - Fee Related KR101204145B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51839103P 2003-11-07 2003-11-07
US60/518,391 2003-11-07
PCT/US2004/036574 WO2005047215A2 (en) 2003-11-07 2004-11-03 Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto

Publications (2)

Publication Number Publication Date
KR20060131771A KR20060131771A (ko) 2006-12-20
KR101204145B1 true KR101204145B1 (ko) 2012-11-22

Family

ID=34590258

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067011065A Expired - Fee Related KR101204145B1 (ko) 2003-11-07 2004-11-03 비시클로〔３．１．０〕헥산 유도체의 제조 방법, 및 이에 대한 중간체

Country Status (10)

Country Link
US (1) US7786314B2 (enExample)
EP (1) EP1689727A4 (enExample)
JP (1) JP4742239B2 (enExample)
KR (1) KR101204145B1 (enExample)
CN (2) CN100475800C (enExample)
AU (1) AU2004289652B8 (enExample)
CA (1) CA2544560C (enExample)
RU (1) RU2388747C2 (enExample)
TW (1) TWI347316B (enExample)
WO (1) WO2005047215A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5309680B2 (ja) * 2008-05-09 2013-10-09 大正製薬株式会社 フッ素化エステル化合物の製造方法及びその中間体
WO2009142184A1 (ja) * 2008-05-21 2009-11-26 大正製薬株式会社 酵素を用いたビシクロ［３．１．０］ヘキサン誘導体の製造方法
US8742161B2 (en) * 2009-11-18 2014-06-03 Taisho Pharmaceutical Co., Ltd Process for producing optically active bicyclo [3.1.0] hexane derivative using enzyme
CN112074505B (zh) 2018-03-08 2024-04-05 因赛特公司 作为PI3K-γ抑制剂的氨基吡嗪二醇化合物
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058258A1 (en) * 1999-03-25 2000-10-05 Taisho Pharmaceutical Co., Ltd. Novel carboxylic acid derivatives and process for producing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152925C1 (ru) * 1994-08-12 2000-07-20 Эли Лилли Энд Компани Производные аминобицикло[3.1.0]гексан-2,6-дикарбоновой кислоты и фармацевтическая композиция
US5661184A (en) 1994-08-12 1997-08-26 Eli Lilly And Company Psychiatric agents
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
JP2000072731A (ja) * 1998-08-31 2000-03-07 Taisho Pharmaceut Co Ltd ４−置換−２−アミノビシクロ［３．１．０］ヘキサン−２，６−ジカルボン酸誘導体及び製薬用組成物
JP4194715B2 (ja) * 1998-08-31 2008-12-10 大正製薬株式会社 ６−フルオロビシクロ［３．１．０］ヘキサン誘導体
CN1247527C (zh) * 1998-08-31 2006-03-29 大正制药株式会社 6－氟双环[3.1.0]己烷衍生物
PE20001236A1 (es) 1998-11-13 2000-11-10 Lilly Co Eli Moduladores del receptor de aminoacidos excitadores
AU6785501A (en) 2000-06-28 2002-01-08 Taisho Pharmaceutical Co Ltd Intermediate and process for producing fluorinated carboxylic acid derivative from the same
CA2441127A1 (en) * 2001-03-14 2002-09-19 Taisho Pharmaceutical Co., Ltd. Process for producing bicyclocarboxylic acid derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058258A1 (en) * 1999-03-25 2000-10-05 Taisho Pharmaceutical Co., Ltd. Novel carboxylic acid derivatives and process for producing the same

Also Published As

Publication number Publication date
EP1689727A2 (en) 2006-08-16
US20070112030A1 (en) 2007-05-17
CA2544560C (en) 2014-01-07
JP4742239B2 (ja) 2011-08-10
CA2544560A1 (en) 2005-05-26
HK1096971A1 (en) 2007-06-15
RU2006119924A (ru) 2007-12-27
EP1689727A4 (en) 2008-12-31
TW200530178A (en) 2005-09-16
WO2005047215A2 (en) 2005-05-26
CN100475800C (zh) 2009-04-08
JP2007513070A (ja) 2007-05-24
CN101654410B (zh) 2013-03-06
CN1898224A (zh) 2007-01-17
AU2004289652B8 (en) 2011-01-20
CN101654410A (zh) 2010-02-24
TWI347316B (en) 2011-08-21
US7786314B2 (en) 2010-08-31
AU2004289652A1 (en) 2005-05-26
KR20060131771A (ko) 2006-12-20
HK1139124A1 (en) 2010-09-10
AU2004289652B2 (en) 2010-09-16
RU2388747C2 (ru) 2010-05-10
WO2005047215A3 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
CN108948039B (zh) 用于合成软海绵素b类似物的中间体和方法
RU2464266C2 (ru) СПОСОБЫ ПОЛУЧЕНИЯ ГЕКСАГИДРОФУРО[2,3-b] ФУРАН-3-ОЛА
CN104876896A (zh) 用于制备软海绵素b的类似物的中间体
RS62515B1 (sr) Prekursor leka – derivat aminokiselina
CN1938316A (zh) 制备(3R,3aS,6aR)六氢－呋喃并[2,3－b]呋喃－3－醇的方法
CN108997267A (zh) 用于制备软海绵素b的类似物的中间体
KR101204145B1 (ko) 비시클로〔３．１．０〕헥산 유도체의 제조 방법, 및 이에 대한 중간체
RU2448957C2 (ru) Фторированные производные катарантина, их получение и применение в качестве прекурсоров димерных алкалоидов vinca
AU2018340858B2 (en) Chiral auxiliaries and uses thereof
JP5960130B2 (ja) テセタキセルおよび関連化合物ならびに対応する合成中間体の調製
JP2016519669A (ja) ジフルオロラクタムアナログを合成する方法
KR100680080B1 (ko) 신규 카르복실산 유도체 및 그의 제조 방법
KR20180004810A (ko) 네비볼롤 합성방법 및 그의 중간 화합물
MXPA06005039A (en) Processes for preparing bicyclo [3.1.0]hexane derivatives, and intermediates thereto
HK1139124B (en) Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
HK1096971B (en) Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
WO2024032799A1 (en) Preparation Method of Tetrodotoxin and its Analog
JP2022529064A (ja) チオ―ルまたはジスルフィド含有メイタンシノイドエステルおよびその中間体の調製のためのジアステロ選択的方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20151117

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20151117